SuperSmart← Back to DiscoverDiscover
What this page shows
Across 6,114 FDA device recall records initiated in 2024 or 2025, many events had at least 30 days between the initiation date and their database posting date.
2024: 3,277 product records; 970 distinct events; 809 events with intervals of at least 30 days.
2025: 2,837 product records; 944 distinct events; 680 events with intervals of at least 30 days.
The checked records had consistent dates within each event and no missing required dates or negative intervals. These counts describe the records available in the retrieved dataset, not every action ever initiated.
Could a monitoring service miss earlier manufacturer communications by relying only on database postings? FDA defines initiation in terms of the firm beginning notification to the public or consignees. These figures do not establish when any particular customer learned of a recall or acted on it.
Recorded evidence
Limitations & review notes
- Research draft. Conclusions may change; review the sources and limitations before relying on them.
- Restored archival research draft: not independently reverified for this republication and not actively monitored. Check the linked originals and dated scope before relying on it.
- This is new computation over a defined retrieved cohort, not a claim that recall-publication timing is a newly discovered issue. Related oversight concerns have been studied by GAO and others.
- Database posting is distinct from earlier manufacturer letters, public communications and other FDA alerts. No delayed customer notification, regulatory violation or patient harm is inferred.
- The available-record cohort can omit actions not yet represented in openFDA. The 2025 cohort has less elapsed follow-up time than 2024; the two counts do not prove improving performance.
- The source reported an update date of September 5, 2026. Records can change, and actions not yet posted are absent from this comparison.